mRNA

All articles by mRNA

Moderna partners with OpenAI to supercharge mRNA research with genAI
Moderna partners with OpenAI to supercharge mRNA research with genAI
Lecia Bushak
April 24, 2024
1:30 pm

Moderna announced a partnership with OpenAI, the company behind ChatGPT, to further incorporate AI across its mRNA drug development and manufacturing operations.

Katalin Karikó and Drew Weissman earn Nobel Prize for mRNA research
Katalin Karikó and Drew Weissman earn Nobel Prize for mRNA research
Jack O'Brien
October 2, 2023
11:31 am

Karikó and Weissman have been at the forefront of research that led to the development and modification of mRNA-based therapies that enabled effective COVID-19 vaccines.

Merck, Moderna launch Phase 3 trial for mRNA vax in combination with Keytruda
Merck, Moderna launch Phase 3 trial for mRNA vax in combination with Keytruda
Lecia Bushak
July 26, 2023
12:48 pm

The Phase 3 trial from Merck and Moderna will investigate the safety and efficacy of mRNA vaccine V940 in combination with Keytruda in melanoma patients.

Moderna and IBM join forces to advance mRNA technology with generative AI
Moderna and IBM join forces to advance mRNA technology with generative AI
Lecia Bushak
April 20, 2023
1:12 pm

Moderna and IBM struck a deal to provide the vaccine maker with generative artificial intelligence that will help it develop mRNA therapies.

‘Welcome to the mRNAge’: Moderna launches global mRNA campaign
‘Welcome to the mRNAge’: Moderna launches global mRNA campaign
Jack O'Brien
April 17, 2023
8:00 am

Moderna is among a bevy of healthcare companies repositioning themselves to better assist patients in the months and years to come.

Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Lecia Bushak
March 6, 2023
4:46 pm

Moderna’s new Innovation and Technology Centre (MITC) will be designed to produce up to 250 million mRNA vaccines per year.

Moderna finalizes decade-long mRNA alliance with U.K.
Moderna finalizes decade-long mRNA alliance with U.K.
Jack O'Brien
December 22, 2022
9:25 am

Construction on the state-of-the-art mRNA manufacturing facility is expected to start in early 2023 and produce the first mRNA vaccine in the U.K. in 2025.

Moderna, Merck herald promising mRNA cancer vaccine and Keytruda results
Moderna, Merck herald promising mRNA cancer vaccine and Keytruda results
Jack O'Brien
December 13, 2022
10:23 am

The companies said they plan to discuss the results with regulatory authorities and then initiate a Phase 3 study in melanoma patients in 2023.

  • From Our Partners